Physician profile
Ashly E Joseph
NPI 1063659696
$5,184.84
in general payments reported to CMS, 2019-2025
48 companies · $969 in 2025
The $969 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,535 · 2020: $686 · 2021: $256 · 2022: $325 · 2023: $512 · 2024: $902 · 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,382.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $878.82 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $648.31 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $376.26 | 2019-2021 | |
| Insulet Corporation | $363.65 | 2019-2024 | Omnipod |
| Amgen INC. | $273.00 | 2019-2025 | Tepezza, Evenity, Prolia |
| Xeris Pharmaceuticals, INC. | $212.46 | 2020-2025 | Gvoke Hypopen |
| Mannkind Corporation | $178.84 | 2019-2020 | |
| Madrigal Pharmaceuticals | $163.37 | 2024-2025 | Rezdiffra, Resmetirom |
| Abbott Laboratories | $147.48 | 2019-2025 | Freestyle Libre 3 |
| Radius Health, INC. | $124.61 | 2020-2024 | Tymlos |
| Tandem Diabetes Care, INC. | $120.34 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic Minimed, INC. | $111.44 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.21 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $92.10 | 2019 | |
| Dexcom, INC. | $83.50 | 2019-2024 | Dexcom G6 Transmitter |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $74.80 | 2023 | Tepezza |
| Embecta Corp. | $74.42 | 2024 | |
| Sanofi-Aventis U.S. LLC | $71.95 | 2019-2025 | |
| Abbvie INC. | $71.81 | 2019-2021 | |
| Medtronic, INC. | $67.04 | 2021-2025 | Minimed 780g |
| Ascendis Pharma Endocrinology INC | $62.40 | 2024-2025 | Yorvipath |
| Corcept Therapeutics | $59.04 | 2019-2025 | Korlym |
| Valeritas, INC. | $58.30 | 2019 | |
| Verity Pharmaceuticals INC. | $55.30 | 2024-2025 | Tlando |
| Antares Pharma, INC. | $53.74 | 2020-2024 | Xyosted |
| Recordati_rare_diseases_inc. | $53.41 | 2025 | Isturisa |
| Astellas Pharma US INC | $53.28 | 2025 | Veozah |
| Shire North American Group INC | $51.64 | 2019 | |
| Chiesi USA, INC. | $44.77 | 2024-2025 | Myalept |
| Ultragenyx Pharmaceutical INC. | $43.20 | 2020-2023 | |
| Averitas Pharma INC. | $43.16 | 2024 | Qutenza |
| Amneal Pharmaceuticals LLC | $37.15 | 2019-2024 | Unithroid |
| Alexion Pharmaceuticals, INC. | $34.26 | 2025 | Strensiq |
| Companion Medical, INC. | $32.13 | 2019 | |
| Sun Pharmaceutical Industries INC. | $29.73 | 2020 | |
| Senseonics, Incorporated | $27.00 | 2019-2020 | |
| Beta Bionics, INC. | $26.62 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Sequel Med Tech, LLC | $21.39 | 2025 | Twiist |
| Amphastar Pharmaceuticals, INC. | $21.12 | 2024 | |
| Ge Healthcare | $20.72 | 2020 | |
| Ascensia Diabetes Care US INC. | $19.90 | 2020 | |
| Becton, Dickinson and Company | $17.24 | 2019 | |
| Vivus LLC | $15.93 | 2024 | Qsymia |
| Amarin Pharma, INC. | $15.81 | 2019 | |
| Organon LLC | $15.27 | 2025 | Hadlima |
| Zealand Pharma US, INC. | $15.15 | 2021 | |
| Cardiovascular Systems INC. | $11.50 | 2019 | |
| Merck Sharp & Dohme LLC | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashly Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.